These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 19514965)

  • 1. Pharmacokinetics and drug metabolism in the elderly.
    Klotz U
    Drug Metab Rev; 2009; 41(2):67-76. PubMed ID: 19514965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in pharmacokinetics.
    Shi S; Klotz U
    Curr Drug Metab; 2011 Sep; 12(7):601-10. PubMed ID: 21495970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver function and phase I drug metabolism in the elderly: a paradox.
    Schmucker DL
    Drugs Aging; 2001; 18(11):837-51. PubMed ID: 11772124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug dosage in the elderly. Is it rational?
    Turnheim K
    Drugs Aging; 1998 Nov; 13(5):357-79. PubMed ID: 9829164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic crisis in the elderly.
    ElDesoky ES
    Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy in the elderly.
    Turnheim K
    Exp Gerontol; 2004; 39(11-12):1731-8. PubMed ID: 15582289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics in older persons.
    Cusack BJ
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):274-302. PubMed ID: 15903286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug metabolism and drug interactions in the elderly.
    Herrlinger C; Klotz U
    Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):897-918. PubMed ID: 11866484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
    Anderson GD
    Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
    Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
    Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Drugs Aging; 1997 Apr; 10(4):278-89. PubMed ID: 9108988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
    Fenneteau F; Poulin P; Nekka F
    J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.
    Staatz CE; Tett SE
    Drugs Aging; 2005; 22(7):541-57. PubMed ID: 16038570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions.
    Corsonello A; Pedone C; Incalzi RA
    Curr Med Chem; 2010; 17(6):571-84. PubMed ID: 20015034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in pharmacokinetics in elderly patients].
    Nadai M; Katoh M
    Nihon Rinsho; 2013 Jun; 71(6):999-1003. PubMed ID: 23855202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E supplementation and hepatic drug metabolism in humans.
    Clarke MW; Burnett JR; Wu JH; Hodgson JM; Ledowski T; Puddey IB; Croft KD
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):491-6. PubMed ID: 19755916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic changes in aging.
    Cohen JL
    Am J Med; 1986 May; 80(5A):31-8. PubMed ID: 3518444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.